1117 related articles for article (PubMed ID: 30576920)
1. NRF2 and NF-қB interplay in cerebrovascular and neurodegenerative disorders: Molecular mechanisms and possible therapeutic approaches.
Sivandzade F; Prasad S; Bhalerao A; Cucullo L
Redox Biol; 2019 Feb; 21():101059. PubMed ID: 30576920
[TBL] [Abstract][Full Text] [Related]
2. Cerebrovascular and Neurological Disorders: Protective Role of NRF2.
Sivandzade F; Bhalerao A; Cucullo L
Int J Mol Sci; 2019 Jul; 20(14):. PubMed ID: 31336872
[TBL] [Abstract][Full Text] [Related]
3. Antioxidative defense mechanisms controlled by Nrf2: state-of-the-art and clinical perspectives in neurodegenerative diseases.
Lim JL; Wilhelmus MM; de Vries HE; Drukarch B; Hoozemans JJ; van Horssen J
Arch Toxicol; 2014 Oct; 88(10):1773-86. PubMed ID: 25164826
[TBL] [Abstract][Full Text] [Related]
4. Nrf2-induced antioxidant protection: a promising target to counteract ROS-mediated damage in neurodegenerative disease?
de Vries HE; Witte M; Hondius D; Rozemuller AJ; Drukarch B; Hoozemans J; van Horssen J
Free Radic Biol Med; 2008 Nov; 45(10):1375-83. PubMed ID: 18824091
[TBL] [Abstract][Full Text] [Related]
5. Nrf2 Pathway in Age-Related Neurological Disorders: Insights into MicroRNAs.
Paladino S; Conte A; Caggiano R; Pierantoni GM; Faraonio R
Cell Physiol Biochem; 2018; 47(5):1951-1976. PubMed ID: 29969760
[TBL] [Abstract][Full Text] [Related]
6. Oxidative stress, mitochondrial dysfunction and cellular stress response in Friedreich's ataxia.
Calabrese V; Lodi R; Tonon C; D'Agata V; Sapienza M; Scapagnini G; Mangiameli A; Pennisi G; Stella AM; Butterfield DA
J Neurol Sci; 2005 Jun; 233(1-2):145-62. PubMed ID: 15896810
[TBL] [Abstract][Full Text] [Related]
7. NRF2-dependent glutamate-L-cysteine ligase catalytic subunit expression mediates insulin protection against hyperglycemia- induced brain endothelial cell apoptosis.
Okouchi M; Okayama N; Alexander JS; Aw TY
Curr Neurovasc Res; 2006 Nov; 3(4):249-61. PubMed ID: 17109620
[TBL] [Abstract][Full Text] [Related]
8. Role of the Keap1/Nrf2 pathway in neurodegenerative diseases.
Yamazaki H; Tanji K; Wakabayashi K; Matsuura S; Itoh K
Pathol Int; 2015 May; 65(5):210-9. PubMed ID: 25707882
[TBL] [Abstract][Full Text] [Related]
9. Quercetin modulates OTA-induced oxidative stress and redox signalling in HepG2 cells - up regulation of Nrf2 expression and down regulation of NF-κB and COX-2.
Ramyaa P; Krishnaswamy R; Padma VV
Biochim Biophys Acta; 2014 Jan; 1840(1):681-92. PubMed ID: 24161694
[TBL] [Abstract][Full Text] [Related]
10. Counteracting role of nuclear factor erythroid 2-related factor 2 pathway in Alzheimer's disease.
Sharma V; Kaur A; Singh TG
Biomed Pharmacother; 2020 Sep; 129():110373. PubMed ID: 32603894
[TBL] [Abstract][Full Text] [Related]
11. Nrf2 deficiency induces oxidative stress and promotes RANKL-induced osteoclast differentiation.
Hyeon S; Lee H; Yang Y; Jeong W
Free Radic Biol Med; 2013 Dec; 65():789-799. PubMed ID: 23954472
[TBL] [Abstract][Full Text] [Related]
12. Inflammation-induced ROS generation causes pancreatic cell death through modulation of Nrf2/NF-κB and SAPK/JNK pathway.
Choudhury S; Ghosh S; Gupta P; Mukherjee S; Chattopadhyay S
Free Radic Res; 2015; 49(11):1371-83. PubMed ID: 26189548
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic Approaches to Alzheimer's Disease Through Modulation of NRF2.
Bahn G; Jo DG
Neuromolecular Med; 2019 Mar; 21(1):1-11. PubMed ID: 30617737
[TBL] [Abstract][Full Text] [Related]
14. Oxidative Stress and Antioxidants in Neurological Diseases: Is There Still Hope?
Carvalho AN; Firuzi O; Gama MJ; Horssen JV; Saso L
Curr Drug Targets; 2017 Mar; 18(6):705-718. PubMed ID: 27033198
[TBL] [Abstract][Full Text] [Related]
15. Shaping the Nrf2-ARE-related pathways in Alzheimer's and Parkinson's diseases.
Fão L; Mota SI; Rego AC
Ageing Res Rev; 2019 Sep; 54():100942. PubMed ID: 31415806
[TBL] [Abstract][Full Text] [Related]
16. Gnaq Protects PC12 Cells from Oxidative Damage by Activation of Nrf2 and Inhibition of NF-kB.
Sun X; Li GP; Huang P; Wei LG; Guo JZ; Ao LJ; Lu D; Chen SC
Neuromolecular Med; 2020 Sep; 22(3):401-410. PubMed ID: 32253686
[TBL] [Abstract][Full Text] [Related]
17. Nrf2--a therapeutic target for the treatment of neurodegenerative diseases.
Johnson DA; Johnson JA
Free Radic Biol Med; 2015 Nov; 88(Pt B):253-267. PubMed ID: 26281945
[TBL] [Abstract][Full Text] [Related]
18. [Role of Nrf2 in neurodegenerative diseases and recent progress of its activators].
Zhao CY; Wang XL; Peng Y
Yao Xue Xue Bao; 2015 Apr; 50(4):375-84. PubMed ID: 26223117
[TBL] [Abstract][Full Text] [Related]
19. The role of Nrf2 signaling in counteracting neurodegenerative diseases.
Dinkova-Kostova AT; Kostov RV; Kazantsev AG
FEBS J; 2018 Oct; 285(19):3576-3590. PubMed ID: 29323772
[TBL] [Abstract][Full Text] [Related]
20. Isoliquiritigenin alleviates early brain injury after experimental intracerebral hemorrhage via suppressing ROS- and/or NF-κB-mediated NLRP3 inflammasome activation by promoting Nrf2 antioxidant pathway.
Zeng J; Chen Y; Ding R; Feng L; Fu Z; Yang S; Deng X; Xie Z; Zheng S
J Neuroinflammation; 2017 Jun; 14(1):119. PubMed ID: 28610608
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
